Coagulation factor Xa (3.4.21.6)

Industry

CPC
C12Y304/21006

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y304/00Hydrolases acting on peptide bonds

Current Industry

C12Y304/21006Coagulation factor Xa (3.4.21.6)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Antidotes to factor XA inhibitors
- Patent number 12,195,774
- Issue date Jan 14, 2025
- Alexion Pharmaceuticals, Inc.
- Pamela B. Conley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prohemostatic proteins for the treatment of bleeding
- Patent number 12,083,170
- Issue date Sep 10, 2024
- Academisch Ziekenhuis Leiden
- Daniël Verhoef
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Lyophilized formulations for factor XA antidote
- Patent number 12,005,144
- Issue date Jun 11, 2024
- Alexion Pharmaceuticals, Inc.
- Phuong M. Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antidotes for factor Xa inhibitors and methods of using the same
- Patent number 11,839,646
- Issue date Dec 12, 2023
- Alexion Pharmaceuticals, Inc.
- Genmin Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Extracellular histones as biomarkers for prognosis and molecular ta...
- Patent number 11,458,187
- Issue date Oct 4, 2022
- Oklahoma Medical Research Foundation
- Charles T. Esmon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Prohemostatic proteins for the treatment of bleeding
- Patent number 11,357,836
- Issue date Jun 14, 2022
- Academisch Ziekenhuis Leiden
- Daniël Verhoef
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prohemostatic proteins for the treatment of bleeding
- Patent number 11,304,995
- Issue date Apr 19, 2022
- Academisch Ziekenhuis Leiden
- Daniël Verhoef
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric clotting factors
- Patent number 11,168,316
- Issue date Nov 9, 2021
- Bioverativ Therapeutics, Inc.
- Joe Salas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions of human prothrombin and activated factor X for improv...
- Patent number 11,160,850
- Issue date Nov 2, 2021
- Takeda Pharmaceutical Company Limited
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Clotting composition
- Patent number 11,103,560
- Issue date Aug 31, 2021
- Q-SERA PTY LTD.
- Paul Masci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutated factor X polypeptides and uses thereof for the treatment of...
- Patent number 11,085,032
- Issue date Aug 10, 2021
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- Olivier Christophe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Lyophilized formulations for factor Xa antidote
- Patent number 11,028,382
- Issue date Jun 8, 2021
- Alexion Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antidotes for factor Xa inhibitors and methods of using the same
- Patent number 10,954,503
- Issue date Mar 23, 2021
- Alexion Pharmaceuticals, Inc.
- Uma Sinha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Clotting composition
- Patent number 10,786,553
- Issue date Sep 29, 2020
- Q-SERA PTY LTD.
- Paul Masci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Unit dose formulation of antidotes for factor Xa inhibitors and met...
- Patent number 10,765,726
- Issue date Sep 8, 2020
- Portola Pharmaceuticals, Inc.
- Uma Sinha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tissue factor (TF)—targeted nanotherapy
- Patent number 10,738,294
- Issue date Aug 11, 2020
- Melina R. Kibbe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antidotes for factor Xa inhibitors and methods of using the same
- Patent number 10,675,335
- Issue date Jun 9, 2020
- Portola Pharmaceuticals, Inc.
- Genmin Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mutated factor X polypeptides and uses thereof for the treatment of...
- Patent number 10,676,730
- Issue date Jun 9, 2020
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- Olivier Christophe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mutated factor X polypeptides and uses thereof for the treatment of...
- Patent number 10,655,119
- Issue date May 19, 2020
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- Olivier Christophe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Non-cytotoxic protein conjugates
- Patent number 10,619,146
- Issue date Apr 14, 2020
- Ipsen Bioinnovation Limited
- Keith Foster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for counteracting Factor Xa inhibition
- Patent number 10,588,950
- Issue date Mar 17, 2020
- Pfizer Inc.
- Debra D. Pittman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of manufacturing and purifying prothrombin complex concentra...
- Patent number 10,583,179
- Issue date Mar 10, 2020
- Kieu Hoang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
One component fibrin glue comprising zymogens
- Patent number 10,555,991
- Issue date Feb 11, 2020
- Omrix Biopharmaceuticals Ltd.
- Yair Pilpel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prohemostatic proteins for the treatment of bleeding
- Patent number 10,537,618
- Issue date Jan 21, 2020
- Academisch Ziekenhuis Leiden
- Daniël Verhoef
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor X mutants
- Patent number 10,364,424
- Issue date Jul 30, 2019
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Jean-Luc Plantier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Extracellular histones as biomarkers for prognosis and molecular ta...
- Patent number 10,350,261
- Issue date Jul 16, 2019
- Oklahoma Medical Research Foundation
- Charles T. Esmon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for universal determination of anticoagulant activity
- Patent number 10,337,048
- Issue date Jul 2, 2019
- Roche Diagnostics Operations, Inc.
- Friedrich Ackermann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Extracellular histones as biomarkers for prognosis and molecular ta...
- Patent number 10,238,711
- Issue date Mar 26, 2019
- Oklahoma Medical Research Foundation
- Charles T. Esmon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric clotting factors
- Patent number 10,202,595
- Issue date Feb 12, 2019
- Bioverativ Therapeutics Inc.
- Joe Salas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antidotes for factor Xa inhibitors and methods of using the same
- Patent number 10,190,111
- Issue date Jan 29, 2019
- Portola Pharmaceuticals, Inc.
- Uma Sinha
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING
- Publication number 20240390467
- Publication date Nov 28, 2024
- Academisch Ziekenhuis Leiden
- Daniël VERHOEF
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...
- Publication number 20240189401
- Publication date Jun 13, 2024
- Alexion Pharmaceuticals, Inc.
- Uma Sinha
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS
- Publication number 20240101973
- Publication date Mar 28, 2024
- The University of North Carolina at Chapel Hill
- Darrel W. Stafford
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
- Publication number 20240082367
- Publication date Mar 14, 2024
- Alexion Pharmaceuticals, Inc.
- Genmin Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR
- Publication number 20230383276
- Publication date Nov 30, 2023
- Alexion Pharmaceuticals, Inc.
- Genmin Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...
- Publication number 20230000957
- Publication date Jan 5, 2023
- Alexion Pharmaceuticals, Inc.
- Uma Sinha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20220354792
- Publication date Nov 10, 2022
- Alexion Pharmaceuticals, Inc.
- Phuong M. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING
- Publication number 20220288172
- Publication date Sep 15, 2022
- Academisch Ziekenhuis Leiden
- Daniël VERHOEF
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS
- Publication number 20220228131
- Publication date Jul 21, 2022
- The University of North Carolina at Chapel Hill
- Darrel W. Stafford
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT P...
- Publication number 20220177856
- Publication date Jun 9, 2022
- The University of North Carolina at Chapel Hill
- Darrel W. Stafford
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC CLOTTING FACTORS
- Publication number 20220135959
- Publication date May 5, 2022
- Bioverativ Therapeutics Inc.
- Joe SALAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR TREATING INTRACRANIAL HEMORRHAGE AND ASSESSING EFFICACY
- Publication number 20220125894
- Publication date Apr 28, 2022
- Alexion Pharmaceuticals, Inc.
- Patrick Yue
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR
- Publication number 20220098565
- Publication date Mar 31, 2022
- Alexion Pharmaceuticals, Inc.
- Genmin Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVA...
- Publication number 20210379163
- Publication date Dec 9, 2021
- Alexion Pharmaceuticals, Inc.
- Genmin Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
- Publication number 20210340515
- Publication date Nov 4, 2021
- Alexion Pharmaceuticals, Inc.
- Uma Sinha
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT P...
- Publication number 20210332333
- Publication date Oct 28, 2021
- The University of North Carolina at Chapel Hill
- Darrel W. Stafford
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FX ACTIVATION PROCESS AND ITS USE IN THE PREPARATION OF A FXA COMPO...
- Publication number 20210290738
- Publication date Sep 23, 2021
- Octapharma AG
- Juergen Roland ROEMISCH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20210284986
- Publication date Sep 16, 2021
- Alexion Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS
- Publication number 20210130795
- Publication date May 6, 2021
- The University of North Carolina at Chapel Hill
- Darrel W. Stafford
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...
- Publication number 20210085762
- Publication date Mar 25, 2021
- Portola Pharmaceuticals, Inc.
- UMA SINHA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CLOTTING COMPOSITION
- Publication number 20210000925
- Publication date Jan 7, 2021
- Q-Sera PTY LTD
- Paul MASCI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION
- Publication number 20210000930
- Publication date Jan 7, 2021
- Pfizer Inc.
- Debra D. Pittman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF...
- Publication number 20200299666
- Publication date Sep 24, 2020
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Olivier CHRISTOPHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20200299667
- Publication date Sep 24, 2020
- Portola Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20200299668
- Publication date Sep 24, 2020
- Portola Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
- Publication number 20200276280
- Publication date Sep 3, 2020
- Portola Pharmaceuticals, Inc.
- GENMIN LU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS
- Publication number 20200263148
- Publication date Aug 20, 2020
- The University of North Carolina at Chapel Hill
- Darrel W. Stafford
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF...
- Publication number 20200248162
- Publication date Aug 6, 2020
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Olivier CHRISTOPHE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT P...
- Publication number 20200224177
- Publication date Jul 16, 2020
- The University of North Carolina at Chapel Hill
- Darrel W. Stafford
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING
- Publication number 20200138917
- Publication date May 7, 2020
- Academisch Ziekenhuis Leiden
- Daniël VERHOEF
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Coagulation factor Xa (3.4.21.6)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Antidotes to factor XA inhibitors

Prohemostatic proteins for the treatment of bleeding

Lyophilized formulations for factor XA antidote

Antidotes for factor Xa inhibitors and methods of using the same

Extracellular histones as biomarkers for prognosis and molecular ta...

Prohemostatic proteins for the treatment of bleeding

Prohemostatic proteins for the treatment of bleeding

Chimeric clotting factors

Compositions of human prothrombin and activated factor X for improv...

Clotting composition

Mutated factor X polypeptides and uses thereof for the treatment of...

Lyophilized formulations for factor Xa antidote

Antidotes for factor Xa inhibitors and methods of using the same

Clotting composition

Unit dose formulation of antidotes for factor Xa inhibitors and met...

Tissue factor (TF)—targeted nanotherapy

Antidotes for factor Xa inhibitors and methods of using the same

Mutated factor X polypeptides and uses thereof for the treatment of...

Mutated factor X polypeptides and uses thereof for the treatment of...

Non-cytotoxic protein conjugates

Compositions and methods for counteracting Factor Xa inhibition

Method of manufacturing and purifying prothrombin complex concentra...

One component fibrin glue comprising zymogens

Prohemostatic proteins for the treatment of bleeding

Factor X mutants

Extracellular histones as biomarkers for prognosis and molecular ta...

Methods for universal determination of anticoagulant activity

Extracellular histones as biomarkers for prognosis and molecular ta...

Chimeric clotting factors

Antidotes for factor Xa inhibitors and methods of using the same

Patents Applicationslast 30 patents

PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING

UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...

METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS

ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR

UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING

METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS

METHODS AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT P...

CHIMERIC CLOTTING FACTORS

METHODS FOR TREATING INTRACRANIAL HEMORRHAGE AND ASSESSING EFFICACY

PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR

INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVA...

ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

METHODS AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT P...

FX ACTIVATION PROCESS AND ITS USE IN THE PREPARATION OF A FXA COMPO...

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS

UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...

CLOTTING COMPOSITION

COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION

MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF...

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS

MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF...

METHODS AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT P...

PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING